 "Merck's pharma production plant in Nantong (China)")
Merck hit a 52-week high of Rs 906, up 13% on BSE in intra-day trade after the company reported more than double net profit at Rs 27.54 crore for the quarter ended September 30, 2016 (Q3CY16). The multi-national pharmaceutical company had posted a profit of Rs 12.51 crore in the same quarter last year.
Total operational income of the company during the quarter under review increased by 5% at Rs 269 crore against Rs 256 crore in the corresponding quarter of previous fiscal.
At 10:46 am, the stock was up 6% at Rs 847 on BSE, as compared to 1.3% decline in the S&P BSE Sensex. A combined 177,510 shares changed hands on the counter on BSE and NSE so far.
Total operational income of the company during the quarter under review increased by 5% at Rs 269 crore against Rs 256 crore in the corresponding quarter of previous fiscal.
At 10:46 am, the stock was up 6% at Rs 847 on BSE, as compared to 1.3% decline in the S&P BSE Sensex. A combined 177,510 shares changed hands on the counter on BSE and NSE so far.
